Most Read Articles
5 days ago
Among postmenopausal women, short sleep duration and depression contribute to increased fall accidents, as reported in a study.
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.

TB prevalence high in MDR-TB household contacts

Roshini Claire Anthony
08 Apr 2020

A high number of household contacts (HHCs) of adults with multi-drug-resistant tuberculosis (MDR-TB) will develop the infection, according to the PHOENIx Feasibility study presented at CROI 2020.

“Over two-thirds of HHCs aged 15 years of adult pulmonary MDR-TB cases had evidence of TB infection [as determined by interferon-gamma release assays (IGRA)],” said study author Dr Soyeon Kim from Frontier Science Foundation in Brookline, Massachusetts, US.

The study was conducted at 16 sites in eight countries with high TB burden. The study population comprised 276 index cases (adults with pulmonary MDR-TB who initiated treatment within the past 6 months [median 9 weeks]; median age 35.5 years, 41 percent female) and 686 of their household contacts aged 15 years (median age 35 years, 64 percent female). Thirty-six and eight percent of the index cases and HHCs, respectively, were HIV-infected.

Overall, 68.8 percent of HHCs had TB infection. This varied across age groups with TB infection detected in 58.0 percent of the 184 HHCs aged 15–24 years, 75.6 percent of the 334 HHCs aged 25–49 years, and 67.2 percent of the 168 HHCs aged 50 years. [CROI 2020, abstract 139]

Multivariable analysis revealed factors associated with TB prevalence in HHCs including age (odds ratio [OR], 1.5 and OR, 0.7 in individuals aged 25–49 and 15–24 years, respectively vs 50 years; p<0.001), previous TB treatment (OR, 1.9; p=0.049), history of incarceration or substance or alcohol use (OR, 7.3 vs none; p<0.001), presence of smoker in the household (OR, 1.6; p=0.029), and low quality home primary exterior wall material (eg, adobe, rammed earth, sticks, stones, mud, wood, etc; OR, 1.8 vs brick, cinderblock, stone with mortar; p=0.008).

Sleeping proximity with the index case was also associated with a higher prevalence (same room: OR, 2.4; p=0.04; different room 6–7 and 3–5 nights/week: OR, 2.1 and 1.8, respectively).

There was no association between sex and increased TB infection prevalence in HHCs. A higher prevalence was noted in HHCs with COPD or asthma history, and in those whose fathers were the index cases though these were not statistically significant.

Repeat IGRA testing of 177 HCCs 1 year later showed that 25.5 percent who tested negative or with indeterminate status at previous assessment developed TB infection.

The study also revealed that the use of TB preventive therapy was uncommon. Regardless of age, only 5 percent of high-risk HCCs eligible for TB preventive treatment received it (eg, 26 percent aged <5 years and 13 percent with HIV).

“The high prevalence and continued incidence of TB infection in HHCs of MDR-TB patients suggests that household contact investigation may be critical to global TB control efforts,” said Kim.

 

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Among postmenopausal women, short sleep duration and depression contribute to increased fall accidents, as reported in a study.
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.